Cardiopulmonary responses and prognosis in hypertrophic cardiomyopathy. A potential role for comprehensive noninvasive hemodynamic assessment.

JACC: Heart Failure

Volumn 3, Issue 5, 2015, Pages 408-418

  Finocchiaro, Gherardo ^a,b   Haddad, Francois ^a,c   Knowles, Joshua W ^a,c   Caleshu, Colleen ^a   Pavlovic, Aleksandra ^a   Homburger, Julian ^a   Shmargad, Yael ^a   Sinagra, Gianfranco ^d   Magavern, Emma ^a   Wong, Myo ^e   Perez, Marco ^a   Schnittger, Ingela ^a,c   Myers, Jonathan ^e   Froelicher, Victor ^e   Ashley, Euan A ^a,c  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c STANFORD UNIVERSITY   (United States)

^d UNIVERSITY OF TRIESTE   (Italy)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Cardiopulmonary test; Echocardiography; Heart failure; Hypertrophic cardiomyopathy

Indexed keywords

ADULT; ALCOHOL SEPTAL ABLATION; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY FUNCTION; CLINICAL ASSESSMENT; CONTROLLED STUDY; DETERIORATION; EXERCISE; FEMALE; FOLLOW UP; HEART DEATH; HEART GRAFT; HEART INDEX; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPEDANCE CARDIOGRAPHY; INDEXED LEFT ATRIAL VOLUME; INDEXED RIGHT VENTRICULAR ENDDIASTOLIC AREA; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE PROCEDURE; MUSCLE RESECTION; PRIORITY JOURNAL; PROGNOSIS; STRESS ECHOCARDIOGRAPHY; CARDIOMYOPATHY, HYPERTROPHIC; DISEASE COURSE; DOPPLER ECHOCARDIOGRAPHY; EXERCISE TOLERANCE; HEMODYNAMICS; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY;

CARDIOMYOPATHY, HYPERTROPHIC; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TOLERANCE; FEMALE; HEMODYNAMICS; HUMANS; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS;

EID: 84929028915     PISSN: 22131779     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchf.2014.11.011     Document Type: Article

References (35)

1. Maron B.J., Maron M.S. Hypertrophic cardiomyopathy. Lancet 2012, 381:242-255.
2. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002, 287:1308-1320.
3. Olivotto I., Cecchi F., Poggesi C., Yacoub M.H. Patterns of disease progression in hypertrophic cardiomyopathy: an individualized approach to clinical staging. Circ Heart Fail 2012, 5:535-546.
4. Frenneaux M.P., Porter A., Caforio A.L., Odawara H., Counihan P.J., McKenna W.J. Determinants of exercise capacity in hypertrophic cardiomyopathy. JAm Coll Cardiol 1989, 13:1521-1526.
5. Efthimiadis G.K., Giannakoulas G., Parcharidou D.G., et al. Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy. Int J Cardiol 2011, 153:179-184.
6. Arena R., Sietsema K.E. Cardiopulmonary exercise testing in the clinical evaluation of patients with heart and lung disease. Circulation 2011, 123:668-680.
7. Balady G.J., Arena R., Sietsema K., et al. Clinician'sguide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation 2010, 122:191-225.
8. Cattadori G., Salvioni E., Gondoni E., Agostoni P. Evaluation of noninvasive exercise cardiac output determination in chronic heart failure patients: a proposal of a new diagnostic and prognostic method. JCardiovasc Med (Hagerstown) 2011, 12:19-27.
9. Lang C.C., Agostoni P., Mancini D.M. Prognostic significance and measurement of exercise-derived hemodynamic variables in patients with heart failure. JCard Fail 2007, 13:672-679.
10. Rickham P.P. Human experimentation. Code of ethics of the world medical association. Declaration of Helsinki. Br Med J 1964, 2:177.
11. Binder J., Ommen S.R., Gersh B.J., et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. MayoClinic Proceedings. Mayo Clinic 2006, 81:459-467.
12. Sahn D.J., DeMaria A., Kisslo J., Weyman A. Recommendations regarding quantitation in m-mode echocardiography: results of a survey ofechocardiographic measurements. Circulation 1978, 58:1072-1083.
13. Lang R.M., Bierig M., Devereux R.B., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. JAm Soc Echocardiogr 2005, 18:1440-1463.
14. Le Tourneau T., Messika-Zeitoun D., Russo A., et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. JAm Coll Cardiol 2010, 56:570-578.
15. Zoghbi W.A., Enriquez-Sarano M., Foster E., et al. Recommendations for evaluation of the severity ofnative valvular regurgitation with two-dimensional and Doppler echocardiography. JAm Soc Echocardiogr 2003, 16:777-802.
16. Nishimura R.A., Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease: Doppler echocardiography is the clinician's Rosetta stone. JAm Coll Cardiol 1997, 30:8-18.
17. Yu C.M., Sanderson J.E., Marwick T.H., Oh J.K. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. JAm Coll Cardiol 2007, 49:1903-1914.
18. Rudski L.G., Lai W.W., Afilalo J., et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010, 23:685-713. quiz 786-788.
19. Borg G. Psychophysical scaling with applications in physical work and the perception of exertion. Scand J Work Environ Health 1990, 16(Suppl 1):55-58.
20. Myers J., Buchanan N., Walsh D., et al. Comparison of the ramp versus standard exercise protocols. JAm Coll Cardiol 1991, 17:1334-1342.
21. Myers J., Wong M., Adhikarla C., et al. Cardiopulmonary and noninvasive hemodynamic responses to exercise predict outcomes in heart failure. JCard Fail 2013, 19:101-107.
22. Charloux A., Lonsdorfer-Wolf E., Richard R., et al. Anew impedance cardiograph device for the non-invasive evaluation of cardiac output at restand during exercise: comparison with the "direct" Fick method. Eur J Appl Physiol 2000, 82:313-320.
23. Tordi N., Mourot L., Matusheski B., Hughson R.L. Measurements of cardiac output during constant exercises: comparison of two non-invasive techniques. Int J Sports Med 2004, 25:145-149.
24. Richard R., Lonsdorfer-Wolf E., Charloux A., et al. Non-invasive cardiac output evaluation during a maximal progressive exercise test, using a new impedance cardiograph device. Eur J Appl Physiol 2001, 85:202-207.
25. Lepretre P.M., Koralsztein J.P., Billat V.L. Effect of exercise intensity on relationship between vo2max and cardiac output. Med Sci Sports Exercise 2004, 36:1357-1363.
26. Sharma S., Elliott P., Whyte G., et al. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol 2000, 86:162-168.
27. Le V.V., Perez M.V., Wheeler M.T., Myers J., Schnittger I., Ashley E.A. Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy. Am Heart J 2009, 158:e27-e34.
28. Farinatti P.T., Soares P.P. Cardiac output and oxygen uptake relationship during physical effort in men and women over 60 years old. Eur J Appl Physiol 2009, 107:625-631.
29. Lele S.S., Thomson H.L., Seo H., Belenkie I., McKenna W.J., Frenneaux M.P. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation 1995, 92:2886-2894.
30. Salerno G., D'Andrea A., Bossone E., et al. Association between right ventricular two-dimensional strain and exercise capacity in patients with either idiopathic or ischemic dilated cardiomyopathy. JCardiovasc Med (Hagerstown) 2011, 12:625-634.
31. Methvin A.B., Owens A.T., Emmi A.G., et al. Ventilatory inefficiency reflects right ventricular dysfunction in systolic heart failure. Chest 2011, 139:617-625.
32. Maron M.S., Olivotto I., Betocchi S., et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. NEngl J Med 2003, 348:295-303.
33. Arena R., Myers J., Aslam S.S., Varughese E.B., Peberdy M.A. Peak vo2 and ve/vco2 slope in patients with heart failure: a prognostic comparison. Am Heart J 2004, 147:354-360.
34. Sorajja P., Allison T., Hayes C., Nishimura R.A., Lam C.S., Ommen S.R. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophiccardiomyopathy. Am J Cardiol 2012, 109:1494-1498.
35. Yoshino T., Nakae I., Matsumoto T., Mitsunami K., Horie M. Relationship between exercise capacity and cardiac diastolic function assessed by time-volume curve from 16-frame gated myocardial perfusion SPECT. Ann Nucl Med 2010, 24:469-476.